Tracy Vanderslice

About Tracy Vanderslice

Proven, results driven, pharmaceutical executive with broad end to end development and global experience in the pharmaceutical and biotech industry. Deep experience across multiple therapeutic areas, including oncology, respiratory, infectious diseases, immunology, neurosciences, cardiovascular, and metabolic diseases. Expertise in clinical operations from FTIH through to post-marketing commitments and submissions. Focus on patient centered design, innovative trials, clinical trial diversity, health equity, and digital health - all with a goal to accelerate delivery of medicines to patients in need.

Experience

1. Vice President Clinical Operations

   Gilead Sciences

   May 2022 — Present · Foster City, CA, US

   Biopharma executive with >25 years experience (10 years as Vice President of Clinical Operations) leading large scale,global teams accountable for end-to-end delivery of broad, multi-therapeutic clinical portfolios. Strategic leadership of global clinical operations with a deep focus on performance metrics to advance the pipeline at pace whilst maintaining flawless execution and a focus on quality. Optimization of operating models to deliver cost savings and improve productivity (including creation of offshore hubs, FSP models, and strategic business units within CROs). Deep focus on building high-performing teams and developing talent.Within Gilead, provide strategic leadership of clinical operations, providing the vision and oversight to ensure successful delivery of multiple programs from Phase 1 through Phase IV. Lead a complex and dynamic global organization across multiple countries to deliver the end to end oncology/hematology portfolio. Develop and own the business strategy and strategic roadmap for function, with a lens on the competitive landscape to ensure successful delivery of key milestones. Executive Sponsorship of the Gilead-Hope Site Network Partnership in Oncology. Executive Sponsor for CRO governance and partnerships. Company representative for Transcelerate\'s Integrated Leadership Team. BWH and Harvard MRCT Advisory Board, and DPHARM Strategic Advisory Committee. Depth and expertise in innovative trial design, molecular & companion diagnostics, precision medicine, decentralized trials, clinical trial diversity, submission excellence, and patient centric approaches to reduce burden.

Education

• Thomas Jefferson University

  Masters, Pharmacology

• Wake Forest University

  Bachelor of Science - BS, Biology

Skills

• Biotechnology
• CRO
• Oncology
• Life Sciences
• Clinical Trials
• Clinical Development
• Infectious Diseases
• Pharmaceutical Industry
• Clinical Research
• Clinical Pharmacology
• Drug Discovery
• Management
• Drug Development
• Gcp